Triastek

Founded in July 2015, Triastek is dedicated to the mission of `revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide.` We have created the Melt Extrusion Deposition (MED) 3D printing pharmaceutical process, transforming the delivery, development and production of medicines through digital product development and continuous manufacturing. Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medicines for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation problems, accelerating the development of new drug products and improving the quality of pharmaceuticals. Our vision is to become the world`s most influential intelligent pharmaceutical enterprise.